{
    "name": "dalbavancin",
    "comment": "Rx",
    "other_names": [
        "Dalvance"
    ],
    "classes": [
        "Glycopeptides"
    ],
    "source": "https://reference.medscape.com/drug/dalvance-dalbavancin-999921",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies with use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse developmental outcomes",
            "No treatment-related malformations or embryo-fetal toxicity were observed in pregnant rats or rabbits at clinically relevant exposures of dalbavancin",
            "Treatment of pregnant rats with dalbavancin at 3.5 times the human dose on an exposure basis during early embryonic development and from implantation to the end of lactation resulted in delayed fetal maturation and increased fetal loss, respectively"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There are no data on presence of dalbavancin or its metabolite in human milk, effects on breastfed child, or on milk production",
            "Dalbavancin is excreted in the milk of lactating rats; when a drug is present in animal milk, it is likely that the drug will be present in human milk",
            "The developmental and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for therapy and any potential adverse effects on the breast-fed child from the drug or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Administer via intravenous infusion, using a total infusion time of 30 minutes to minimize risk of infusion-related reaction; rapid IV infusion of glycopeptide antibacterial agents can cause reactions, including upper body flushing, urticaria, pruritus, back pain, and rash; stopping or slowing infusion may result in cessation of these reactions",
                "ALT elevations >3x ULN reported",
                "Prescribing antibiotics in the absence of a proven or strongly suspected bacterial infection, or a prophylactic indication is unlikely to provide benefit and increases the risk of the development of drug-resistant bacteria"
            ],
            "specific": [
                {
                    "type": "Clostridioides difficile-associated diarrhea (CDAD)",
                    "description": [
                        "CDAD reported with severity ranging from mild diarrhea to fatal colitis; treatment with antibacterial agents can alter normal flora of the colon, and may permit overgrowth of C. difficile",
                        "C. difficile produces toxins A and B which contribute to development of CDAD; hypertoxin-producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antibacterial therapy and may require colectomy",
                        "CDAD must be considered in all patients who present with diarrhea following antibacterial use; careful medical history necessary because CDAD has been reported to occur more than 2 months after administration of antibacterial agents",
                        "If CDAD is suspected or confirmed, ongoing antibacterial use not directed against C. difficile should be discontinued, if possible appropriate measures such as fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated"
                    ]
                },
                {
                    "type": "Hypersensitivity reactions",
                    "description": [
                        "Serious hypersensitivity (anaphylactic) and skin reactions reported with glycopeptide antibacterial agents, including dalbavancin",
                        "If an allergic reaction occurs, discontinue treatment and institute appropriate therapy for the allergic reaction; before using product, inquire carefully about previous hypersensitivity reactions to other antimicrobials#glycopeptides",
                        "Due to the possibility of cross-sensitivity, carefully monitor for signs of hypersensitivity during treatment in patients with a history of glycopeptide allergy"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Nausea",
            "percent": "5.5"
        },
        {
            "name": "Headache",
            "percent": "4.7"
        },
        {
            "name": "Diarrhea",
            "percent": "4.4"
        },
        {
            "name": "Vomiting",
            "percent": "2.8"
        },
        {
            "name": "Rash",
            "percent": "2.7"
        },
        {
            "name": "Pruritus",
            "percent": "2.1"
        },
        {
            "name": "Blood and lymphatic system disorders",
            "percent": "1.2"
        },
        {
            "name": "Anemia",
            "percent": "3"
        },
        {
            "name": "hemorrhagic anemia",
            "percent": "0.8"
        },
        {
            "name": "leukopenia",
            "percent": null
        },
        {
            "name": "neutropenia",
            "percent": null
        },
        {
            "name": "thrombocytopenia",
            "percent": null
        },
        {
            "name": "petechiae",
            "percent": null
        },
        {
            "name": "eosinophilia",
            "percent": null
        },
        {
            "name": "thrombocytosis",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Gastrointestinal hemorrhage",
            "percent": null
        },
        {
            "name": "melena",
            "percent": null
        },
        {
            "name": "hematochezia",
            "percent": null
        },
        {
            "name": "abdominal pain",
            "percent": null
        },
        {
            "name": "General disorders and administration site conditions",
            "percent": null
        },
        {
            "name": "Infusion",
            "percent": null
        },
        {
            "name": "related reactions",
            "percent": null
        },
        {
            "name": "Hepatobiliary disorders",
            "percent": null
        },
        {
            "name": "Hepatotoxicity",
            "percent": null
        },
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Anaphylactoid reaction",
            "percent": null
        },
        {
            "name": "Infections and infestations",
            "percent": null
        },
        {
            "name": "Clostridium difficile colitis",
            "percent": null
        },
        {
            "name": "oral candidiasis",
            "percent": null
        },
        {
            "name": "vulvovaginal mycotic infection",
            "percent": null
        },
        {
            "name": "Investigations",
            "percent": null
        },
        {
            "name": "Hepatic transaminases increased",
            "percent": null
        },
        {
            "name": "blood alkaline phosphatase increased",
            "percent": null
        },
        {
            "name": "INR ratio increased",
            "percent": null
        },
        {
            "name": "blood lactate dehydrogenase increased",
            "percent": null
        },
        {
            "name": "gamma",
            "percent": null
        },
        {
            "name": "glutamyl transferase increased",
            "percent": null
        },
        {
            "name": "Metabolism and nutrition disorders",
            "percent": null
        },
        {
            "name": "Hypoglycemia",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic and mediastinal disorders",
            "percent": null
        },
        {
            "name": "Bronchospasm",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "pruritus",
            "percent": null
        },
        {
            "name": "urticaria",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Flushing",
            "percent": null
        },
        {
            "name": "phlebitis",
            "percent": null
        },
        {
            "name": "wound hemorrhage",
            "percent": null
        },
        {
            "name": "spontaneous hematoma",
            "percent": null
        },
        {
            "name": "Pyrexia",
            "percent": null
        },
        {
            "name": "Elevated ALT",
            "percent": null
        },
        {
            "name": "x ULN",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        }
    ]
}